Selection and analysis of an optimized anti-VEGF antibody: Crystal structure of an affinity-matured Fab in complex with antigen

被引:361
作者
Chen, Y
Wiesmann, C
Fuh, G
Li, B
Christinger, HW
McKay, P
de Vos, AM
Lowman, HB
机构
[1] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Proc Sci, San Francisco, CA 94080 USA
关键词
angiogenesis; humanized antibody-antigen complex; affinity maturation; phage display; X-ray crystallography;
D O I
10.1006/jmbi.1999.3192
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Fab portion of a humanized antibody (Fab-12; IgG form known as rhuMAb VEGF) to vascular endothelial growth factor (VEGF) has been affinity-matured through complementarity-determining region (CDR) mutation, followed by affinity selection using monovalent phage display. After stringent binding selections at 37 degrees C, with dissociation (off-rate) selection periods of several days, high affinity variants were isolated from CDR-H1, H2, and H3 libraries. Mutations were combined to obtain cumulatively tighter-binding variants. The final variant identified here, Y0317, contained six mutations from the parental antibody. In vitro cell-based assays show that four mutations yielded an improvement of about 100-fold in potency for inhibition of VEGF-dependent cell proliferation by this variant, consistent with the equilibrium binding constant determined from kinetics experiments at 37 degrees C. Using X-ray crystallography, we determined a high-resolution structure of the complex between VEGF and the affinity-matured Fab fragment. The overall features of the binding interface seen previously with wild-type are preserved, and many contact residues are maintained in precise alignment in the superimposed structures. However, locally, we see evidence for improved contacts between antibody and antigen, and two mutations result in increased van der Waals contact and improved hydrogen bonding. Site-directed mutants confirm that the most favorable improvements as judged by examination of the complex structure, in fact, have the greatest impact on free energy of binding. In general, the final antibody has improved affinity for several VEGF variants as compared with the parental antibody; however, some contact residues on VEGF differ in their contribution to the energetics of Fab binding. The results show that small changes even in a large protein-protein binding interface can have significant effects on the energetics of interaction. (C) 1999 Academic Press.
引用
收藏
页码:865 / 881
页数:17
相关论文
共 48 条
  • [1] Baca M, 1997, J BIOL CHEM, V272, P10678
  • [2] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY
    BAILEY, S
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 760 - 763
  • [3] IN-VITRO EVOLUTION OF A NEUTRALIZING HUMAN-ANTIBODY TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO ENHANCE AFFINITY AND BROADEN STRAIN CROSS-REACTIVITY
    BARBAS, CF
    HU, D
    DUNLOP, N
    SAWYER, L
    CABABA, D
    HENDRY, RM
    NARA, PL
    BURTON, DR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 3809 - 3813
  • [4] HORMONE PHAGE - AN ENRICHMENT METHOD FOR VARIANT PROTEINS WITH ALTERED BINDING-PROPERTIES
    BASS, S
    GREENE, R
    WELLS, JA
    [J]. PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1990, 8 (04): : 309 - 314
  • [5] CRYSTALLOGRAPHIC R-FACTOR REFINEMENT BY MOLECULAR-DYNAMICS
    BRUNGER, AT
    KURIYAN, J
    KARPLUS, M
    [J]. SCIENCE, 1987, 235 (4787) : 458 - 460
  • [6] CANONICAL STRUCTURES FOR THE HYPERVARIABLE REGIONS OF IMMUNOGLOBULINS
    CHOTHIA, C
    LESK, AM
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1987, 196 (04) : 901 - 917
  • [7] DELISI C, 1983, METHOD ENZYMOL, V93, P95
  • [8] Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site
    Fairbrother, WJ
    Christinger, HW
    Cochran, AG
    Fuh, C
    Keenan, CJ
    Quan, C
    Shriver, SK
    Tom, JYK
    Wells, JA
    Cunningham, BC
    [J]. BIOCHEMISTRY, 1998, 37 (51) : 17754 - 17764
  • [9] PITUITARY FOLLICULAR CELLS SECRETE A NOVEL HEPARIN-BINDING GROWTH-FACTOR SPECIFIC FOR VASCULAR ENDOTHELIAL-CELLS
    FERRARA, N
    HENZEL, WJ
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) : 851 - 858
  • [10] THE ROLE OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IN PATHOLOGICAL ANGIOGENESIS
    FERRARA, N
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1995, 36 (02) : 127 - 137